Clinical Trial Update: Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol [NA]

View source ↗

Summary

A clinical trial update investigating whether serum anti-Müllerian hormone levels can predict metaphase II oocyte yield in poor responders undergoing IVF with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Snippet

Sponsor: Cairo University | Conditions: Invitro Fertilizaion | NA | Status: UNKNOWN